# NextCure, Inc.: filings

NXTC · Nasdaq · CIK 1661059 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nxtc.md) · [Financials](/companies/nxtc/financials.md) · [Filings](/companies/nxtc/filings.md) · [Insiders](/companies/nxtc/insiders.md)

## Reports and events: 117 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 128, 8-K 67, 3 29, 10-Q 23, SC 13G/A 11, SC 13G 10, DEFA14A 9, SCHEDULE 13G/A 9, CORRESP 8, 10-K 7, DEF 14A 7, SCHEDULE 13G 7, UPLOAD 7, EFFECT 6, 425 5, S-8 5, S-1/A 4, SEC STAFF LETTER 4, 424B5 3, D 3, DRSLTR 3, S-3 3, SC 13D/A 3, 424B4 2, DRS 2, DRS/A 2, PRE 14A 2, S-1 2, S-4/A 2, SC 13D 2, 10-K/A 1, 3/A 1, 424B1 1, 424B2 1, 8-A12B 1, ARS 1, CERT 1, POS AM 1, POSASR 1, S-1MEF 1, S-3ASR 1, S-4 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 08:00 ET | [8-K](/filings/0001104659-26-120405.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-120405 |
| 2026-09-25 | 16:10 ET | [8-K](/filings/0001104659-26-110971.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-110971 |
| 2026-09-03 | 16:10 ET | [8-K](/filings/0001104659-26-105057.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-105057 |
| 2026-08-06 | 16:25 ET | [10-Q](/filings/0001104659-26-092050.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092050 |
| 2026-08-06 | 16:16 ET | [8-K](/filings/0001104659-26-092025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092025 |
| 2026-07-14 | 07:00 ET | [8-K](/filings/0001104659-26-083326.md) | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-083326 |
| 2026-06-25 | 08:01 ET | [8-K](/filings/0001104659-26-077546.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-077546 |
| 2026-06-01 | 08:10 ET | [8-K](/filings/0001104659-26-068604.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-068604 |
| 2026-05-07 | 16:25 ET | [10-Q](/filings/0001104659-26-057187.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057187 |
| 2026-05-07 | 16:19 ET | [8-K](/filings/0001104659-26-057171.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057171 |
| 2026-04-24 | 16:15 ET | [DEF 14A](/filings/0001104659-26-048591.md) | Proxy statement, period 2026-06-18 | 0001104659-26-048591 |
| 2026-03-05 | 16:26 ET | [10-K](/filings/0001104659-26-024137.md) | Annual report, period 2025-12-31 | 0001104659-26-024137 |
| 2026-03-05 | 16:15 ET | [8-K](/filings/0001104659-26-024121.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-024121 |
| 2026-03-05 | 06:06 ET | [SCHEDULE 13D/A](/filings/0001104659-26-023741.md) | Ownership report, active investor, amended | 0001104659-26-023741 |
| 2026-01-23 | 07:20 ET | [8-K](/filings/0001104659-26-006021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006021 |
| 2025-12-19 | 17:31 ET | [8-K](/filings/0001104659-25-123305.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-123305 |
| 2025-11-17 | 08:20 ET | [8-K](/filings/0001104659-25-112975.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112975 |
| 2025-11-05 | 16:25 ET | [10-Q](/filings/0001104659-25-107036.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107036 |
| 2025-11-05 | 16:16 ET | [8-K](/filings/0001104659-25-107008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107008 |
| 2025-08-25 | 16:11 ET | [8-K](/filings/0001558370-25-011752.md) | 5.02 Departure or appointment of officers or directors | 0001558370-25-011752 |
| 2025-08-07 | 16:27 ET | [10-Q](/filings/0001558370-25-010782.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010782 |
| 2025-08-07 | 16:18 ET | [8-K](/filings/0001558370-25-010774.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010774 |
| 2025-07-14 | 07:15 ET | [8-K](/filings/0001558370-25-009214.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-25-009214 |
| 2025-07-10 | 09:00 ET | [8-K](/filings/0001558370-25-009163.md) | 8.01 Other events | 0001558370-25-009163 |
| 2025-06-23 | 09:15 ET | [8-K](/filings/0001558370-25-008789.md) | 5.07 Shareholder vote results | 0001558370-25-008789 |
| 2025-06-16 | 07:15 ET | [8-K](/filings/0001558370-25-008633.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-008633 |
| 2025-05-01 | 16:25 ET | [10-Q](/filings/0001558370-25-006111.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006111 |
| 2025-05-01 | 16:15 ET | [8-K](/filings/0001558370-25-006106.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006106 |
| 2025-04-25 | 06:04 ET | [DEF 14A](/filings/0001104659-25-038880.md) | Proxy statement, period 2025-06-20 | 0001104659-25-038880 |
| 2025-04-10 | 08:30 ET | [8-K](/filings/0001558370-25-004651.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-004651 |
| 2025-03-06 | 16:26 ET | [10-K](/filings/0001558370-25-002402.md) | Annual report, period 2024-12-31 | 0001558370-25-002402 |
| 2025-03-06 | 16:15 ET | [8-K](/filings/0001558370-25-002396.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002396 |
| 2025-02-03 | 16:10 ET | [8-K](/filings/0001558370-25-000603.md) | 3.01 Delisting notice | 0001558370-25-000603 |
| 2025-01-10 | 08:15 ET | [8-K](/filings/0001558370-25-000099.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000099 |
| 2024-12-10 | 08:10 ET | [8-K](/filings/0001558370-24-016108.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-016108 |
| 2024-12-05 | 07:11 ET | [8-K](/filings/0001558370-24-016026.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-016026 |
| 2024-11-08 | 16:15 ET | [8-K](/filings/0001558370-24-015060.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-015060 |
| 2024-11-07 | 16:15 ET | [10-Q](/filings/0001558370-24-014869.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014869 |
| 2024-11-07 | 16:11 ET | [8-K](/filings/0001558370-24-014866.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014866 |
| 2024-08-01 | 16:15 ET | [10-Q](/filings/0001558370-24-010605.md) | Quarterly report, period 2024-06-30 | 0001558370-24-010605 |
| 2024-08-01 | 16:10 ET | [8-K](/filings/0001558370-24-010598.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-010598 |
| 2024-06-21 | 16:15 ET | [8-K](/filings/0001558370-24-009401.md) | 5.07 Shareholder vote results | 0001558370-24-009401 |
| 2024-06-18 | 16:10 ET | [8-K](/filings/0001558370-24-009282.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-009282 |
| 2024-05-02 | 16:20 ET | [10-Q](/filings/0001558370-24-006551.md) | Quarterly report, period 2024-03-31 | 0001558370-24-006551 |
| 2024-05-02 | 16:10 ET | [8-K](/filings/0001558370-24-006543.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-006543 |
| 2024-04-26 | 16:06 ET | [DEF 14A](/filings/0001104659-24-052922.md) | Proxy statement, period 2024-06-20 | 0001104659-24-052922 |
| 2024-03-21 | 09:05 ET | [10-K](/filings/0001558370-24-003672.md) | Annual report, period 2023-12-31 | 0001558370-24-003672 |
| 2024-03-21 | 09:00 ET | [8-K](/filings/0001558370-24-003671.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-003671 |
| 2024-03-08 | 16:34 ET | [SC 13D/A](/filings/0000947871-24-000274.md) | Ownership report, active investor, amended | 0000947871-24-000274 |
| 2023-12-14 | 07:15 ET | [8-K](/filings/0001558370-23-019766.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-019766 |

Page 1 of 3. [Older](/companies/nxtc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 2, 2026, 06:06 ET. No prices; not investment advice.